Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate

Treatment of active, moderate-to-severe Graves’ orbitopathy (GO) is the administration of intravenous methylprednisolone (IVMP). IVMP may be followed by additional therapy with oral prednisone. The aim of this study was to analyze the impact of IVMP on adrenal function by evaluation of serum, saliva...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelewicz, Katarzyna, Szewczyk, Sebastian, Miśkiewicz, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601692/
https://www.ncbi.nlm.nih.gov/pubmed/33050327
http://dx.doi.org/10.3390/jcm9103233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601692/
https://www.ncbi.nlm.nih.gov/pubmed/33050327
http://dx.doi.org/10.3390/jcm9103233

Ejemplares similares